Correction to : Randomized phase 2 trial of pevonedistat plus azacitidine versus azacitidine for higher-risk MDS/CMML or low-blast AML
| Errataetall: |
ErratumFor: Leukemia. 2021 Jul;35(7):2119-2124. - PMID 33483617 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:35 |
|---|---|
| Enthalten in: |
Leukemia - 35(2021), 12 vom: 17. Dez., Seite 3637 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sekeres, Mikkael A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 21.05.2022 published: Print ErratumFor: Leukemia. 2021 Jul;35(7):2119-2124. - PMID 33483617 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1038/s41375-021-01473-1 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM333274792 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM333274792 | ||
| 003 | DE-627 | ||
| 005 | 20231225221326.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41375-021-01473-1 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1110.xml |
| 035 | |a (DE-627)NLM333274792 | ||
| 035 | |a (NLM)34789825 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sekeres, Mikkael A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Correction to |b Randomized phase 2 trial of pevonedistat plus azacitidine versus azacitidine for higher-risk MDS/CMML or low-blast AML |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 21.05.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a ErratumFor: Leukemia. 2021 Jul;35(7):2119-2124. - PMID 33483617 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 650 | 4 | |a Published Erratum | |
| 700 | 1 | |a Watts, Justin |e verfasserin |4 aut | |
| 700 | 1 | |a Radinoff, Atanas |e verfasserin |4 aut | |
| 700 | 1 | |a Sangerman, Montserrat Arnan |e verfasserin |4 aut | |
| 700 | 1 | |a Cerrano, Marco |e verfasserin |4 aut | |
| 700 | 1 | |a Lopez, Patricia Font |e verfasserin |4 aut | |
| 700 | 1 | |a Zeidner, Joshua F |e verfasserin |4 aut | |
| 700 | 1 | |a Campelo, Maria Diez |e verfasserin |4 aut | |
| 700 | 1 | |a Graux, Carlos |e verfasserin |4 aut | |
| 700 | 1 | |a Liesveld, Jane |e verfasserin |4 aut | |
| 700 | 1 | |a Selleslag, Dominik |e verfasserin |4 aut | |
| 700 | 1 | |a Tzvetkov, Nikolay |e verfasserin |4 aut | |
| 700 | 1 | |a Fram, Robert J |e verfasserin |4 aut | |
| 700 | 1 | |a Zhao, Dan |e verfasserin |4 aut | |
| 700 | 1 | |a Bell, Jill |e verfasserin |4 aut | |
| 700 | 1 | |a Friedlander, Sharon |e verfasserin |4 aut | |
| 700 | 1 | |a Faller, Douglas V |e verfasserin |4 aut | |
| 700 | 1 | |a Adès, Lionel |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Leukemia |d 1989 |g 35(2021), 12 vom: 17. Dez., Seite 3637 |w (DE-627)NLM012593788 |x 1476-5551 |7 nnns |
| 773 | 1 | 8 | |g volume:35 |g year:2021 |g number:12 |g day:17 |g month:12 |g pages:3637 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41375-021-01473-1 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 35 |j 2021 |e 12 |b 17 |c 12 |h 3637 | ||